Drug intelligence / Profile preview

9E,11E-conjugated linoleic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

9E,11E-conjugated linoleic acid (9E,11E-CLA), also known as isolinoleic acid or Mangold's acid, is a specific geometric isomer of linoleic acid with two contiguous double bonds in the all-trans configuration at positions 9 and 11. It is a naturally occurring polyunsaturated fatty acid found in trace amounts in beef fat and dairy products. Unlike more common CLA isomers (such as 9-cis,11-trans), the 9E,11E isomer has demonstrated unique and potent anti-inflammatory, anti-carcinogenic, and anti-atherogenic properties in preclinical research. Its mechanism of action primarily involves the induction of the endogenous anti-inflammatory factor interleukin-1 receptor antagonist (IL-1Ra) through the activation of the phosphoinositide 3-kinase (PI3K) and mechanistic target of rapamycin (mTOR) signaling pathways. This activity leads to the downregulation of several atherogenesis-related genes, including adhesion molecules like ICAM-1 and VCAM-1, and chemokines such as MCP-1. While it shows significant biological potential, 9E,11E-CLA is currently utilized primarily as a research chemical and is not in formal pharmaceutical development by any identified commercial entity.

Other names
9E,11E-CLAisolinoleic acidMangold's acidtrans-9,trans-11-octadecadienoic acid(9E,11E)-octadeca-9,11-dienoic acid9-trans,11-trans-octadecadienoic acid
02

Targets

IL1RN (Interleukin-1 receptor antagonist)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)mTOR (Mammalian target of rapamycin kinase)

Beyond the preview

Go deeper on 9E,11E-conjugated linoleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 9E,11E-conjugated linoleic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call